Literature DB >> 8581473

Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.

B Levant1.   

Abstract

The effects of alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on the binding of [3H]7-OH-DPAT, a ligand for the D3 dopamine receptor, were assessed in ventral striatal (n. accumbens and olf. tubercle) membranes of adult, male Sprague-Dawley rats. [3H]Spiperone binding to D2-like receptors in striatal membranes was also assayed as a positive control. In vitro, EEDQ was equipotent in inactivating [3H]7-OH-DPAT- and [3H]spiperone-labeled binding sites. In vitro, [3H]spiperone binding was rapidly eliminated in a dose-dependent manner following EEDQ administration. In contrast, [3H]7-OH-DPAT binding was not significantly altered by any dose of the alkylating agent at any time point examined. Depletion of endogenous catecholamines with alpha-methyltyrosine and reserpine revealed a second, higher affinity binding site for [3H]7-OH-DPAT. Administration of EEDQ in catecholamine-depleted animals reduced [3H]7-OH-DPAT labels two distinct populations of binding binding sites in rat brain membranes, only one of which is susceptible to inactivation by EEDQ. These sites may represent high and low affinity states of the D3 receptor. In addition, this discovery may provide a useful method for examining the function of some D3 receptors in brain independent of other monoaminergic systems.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581473     DOI: 10.1016/0006-8993(95)00879-u

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study.

Authors:  Robert H Mach; Zhude Tu; Jinbin Xu; Shihong Li; Lynne A Jones; Michelle Taylor; Robert R Luedtke; Colin P Derdeyn; Joel S Perlmutter; Mark A Mintun
Journal:  Synapse       Date:  2011-03-21       Impact factor: 2.562

2.  Behavioral effects of dopamine receptor inactivation during the adolescent period: age-dependent changes in dorsal striatal D2(High) receptors.

Authors:  Sanders A McDougall; Joseph M Valentine; Ashley E Gonzalez; Danielle E Humphrey; Crystal B Widarma; Cynthia A Crawford
Journal:  Psychopharmacology (Berl)       Date:  2013-11-28       Impact factor: 4.530

3.  Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist.

Authors:  Jinbin Xu; Suwanna Vangveravong; Shihong Li; Jinda Fan; Lynne A Jones; Jinquan Cui; Ruike Wang; Zhude Tu; Wenhua Chu; Joel S Perlmutter; Robert H Mach
Journal:  Neuroimage       Date:  2013-01-17       Impact factor: 6.556

4.  Inactivation of 5-HT1A and [3H]5-HT binding sites by N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) in rat brain.

Authors:  M N Subhash; B N Srinivas; K Y Vinod; S Jagadeesh
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

5.  The adverse effects of pramipexole on probability discounting are not reversed by acute D2 or D3 receptor antagonism.

Authors:  Marco Orrù; Hunter J Strathman; Gabriele Floris; Simona Scheggi; Beth Levant; Marco Bortolato
Journal:  Eur Neuropsychopharmacol       Date:  2020-01-24       Impact factor: 5.415

Review 6.  Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo.

Authors:  Béla Kiss; Balázs Krámos; István Laszlovszky
Journal:  Front Psychiatry       Date:  2022-03-24       Impact factor: 4.157

Review 7.  Abnormalities of Dopamine D3 Receptor Signaling in the Diseased Brain.

Authors:  G Aleph Prieto
Journal:  J Cent Nerv Syst Dis       Date:  2017-08-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.